All News

RNL, over, microphone

RheumNow Live 2021 Now Available for All

d Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
CDC study from 33 sites, 25 states showed vaccine efficacy (against Sx COVID) in HCP was 82% with ONEdose (Pfizer, Moderna) and 94% for TWO doses (same as RCTs). The efficacy of only 1 dose (of a 2 dose COVID vax) is likely to be 70- 82%. https://t.co/uQhUmjSsRd

Links:

Dr. John Cush RheumNow ( View Tweet)

masks_0.jpg

CDC: Fully Vaccinated Can Shed Masks and Resume Travel

d Jack Cush, MD

The U.S.

Read Article
Worth sharing again-- ACR Updates COVID-19 Vaccine Guidance- April 2021 The ACR COVID-19 Vaccine Clinical Guidance was originally published on 2/8/21 & updated on 3/4/21. On 4/28/21, new recommendations were added. https://t.co/BgrFxCgjRw https://t.co/O7ngEBEX6s

Links:

Dr. John Cush RheumNow ( View Tweet)
NSAIDs.pills_.caps_.jpg

NSAID Safety with COVID-19 Infection

d Jack Cush, MD

NSAIDs do not affect COVID outcomes; here we are nearly 16 months into the pandemic, and this is the common sense conclusion of a recent trial published in Lancet Rheumatology.

Read Article
281,264 people vax w/ Oxford-AstraZeneca COVID vaccine - had 59 VTEs (30 expected; 2 fold incr.) +Higher than expected cerebral VTE seen (excess of 2.5 100K Vax). Thrombocytopenia/coagulation disorders were rare but not in excess. https://t.co/m3cjqkzHSW

Links:

Dr. John Cush RheumNow ( View Tweet)

27 cases of #immune-mediated diseases post #COVIDVaccination ▶️21 had autoimmune/rheumatic background ▶️17 flares, 10 new onset ▶️Average 4 days post #covidvaccine ▶️>80% had resolution, mostly with corticosteroid 👉🏽https://t.co/zHlFziswU7 via @Vaccines_MDPI @MDPIOpenAccess https://t.co/5ifoBmb9Ux

Links:

Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
#VACOLUP study about #COVID19 #vaccine in #lupus = reassuring data for #SLE patients : side-effects are minor/moderate in 80% and the rate of lupus #flare is stable at 3-4%. Thanks to the 571 patients who have already participated 🙏. Link: https://t.co/I0D52fv4BC https://t.co/us0kQlvkVS

Links:

Laurent ARNAUD Lupusreference ( View Tweet)
News Feature: ACR Updates COVID-19 Vaccine Guidance- April 2021 https://t.co/BgrFxCgjRw

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast square

RheumNow Podcast – Uppers and Downers

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Read Article
ACR, guidance, guidelines

ACR Updates COVID-19 Vaccine Guidance- April 2021

d ACR COVID-19 Vaccine Clinical Guidance Task Force

The ACR COVID-19 Vaccine Clinical Guidance was originally published on February 8, 2021 and updated on March 4, 2021. On April 28, 2021, new recommendations were added regarding mycophenolate, methotrexate, acetaminophen, and NSAID timing considerations,  

Read Article
RheumNow Podcast is Up! – with news of Uppers and Downers. Read about Vaccine success, CKD gout prophylaxis, TOFA in AS & too much IL-17 inhib can be a problem https://t.co/kt63YrQ0Sw Listen iTunes> https://t.co/FHJv01AAbC or Android SoundCloud>>https://t.co/IyYvjkWUc1

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast is Up! – with news of Uppers and Downers. Read about Vaccine success, CKD gout prophylaxis, TOFA in AS & too much IL-17 inhib can be a problem https://t.co/kt63YrQ0Sw Listen iTunes> https://t.co/FHJv01AAbC or Android SoundCloud>>https://t.co/IyYvjkWUc1

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast is Up! – with news of Uppers and Downers. Read about Vaccine success, CKD gout prophylaxis, TOFA in AS & too much IL-17 inhib can be a problem https://t.co/kt63YrQ0Sw Listen iTunes> https://t.co/FHJv01AAbC or Android SoundCloud>>https://t.co/IyYvjkWUc1

Links:

Dr. John Cush RheumNow ( View Tweet)

CDC study shows that adults >65yrs who are fully vaccinated (w/ Pfizer or Moderna) showed 94% drop in COVID-19 hospitalization (64for among partially vaccinated adults) https://t.co/iJrbiNJg2r

Links:

Dr. John Cush RheumNow ( View Tweet)

Take a look at our COVID-19 section of the site to see all articles published on this virus. https://t.co/TiB7739ONL

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. J Curtis discussing ACR’s COVID Vaccine guidance. Testing for antibodies may not be necessary at this time as common lab tests differ in what they target. #RNL2021 https://t.co/Xd0DYiwZEg
Robert B Chao, MD doctorRBC ( View Tweet)
News Feature: New Side Effect From mRNA COVID Vaccines? Herpes zoster reactivation following COVID-19 vaccination in 6 patients with comorbid autoimmune/inflammatory diseases may be a new adverse event associated with the Pfizer/BioNTech mRNA vaccine. https://t.co/GgjoIpYDkC https://t.co/sI2Fx0o05G

Links:

Dr. John Cush RheumNow ( View Tweet)
shingles2.jpg

New Side Effect From mRNA COVID Vaccines?

d MedPage Today

Herpes zoster reactivation -- a.k.a. shingles -- following COVID-19 vaccination in six patients with comorbid autoimmune/inflammatory diseases may be a new adverse event associated with the Pfizer/BioNTech mRNA vaccine, suggested a new report.

Read Article
News Feature: Planes, Trains and COVID Distancing MMWR reports the risk of acquiring an infection with SARS-CoV-2 is reduced 23% to 57% when the middle seat was vacant (compared with full aircraft occupancy). https://t.co/tGs9GopeGu https://t.co/ZRMltTpYgW

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×